These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 30572596)

  • 1. S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer.
    Noye TM; Lokman NA; Oehler MK; Ricciardelli C
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A2 and S100A10 are independent predictors of serous ovarian cancer outcome.
    Lokman NA; Pyragius CE; Ruszkiewicz A; Oehler MK; Ricciardelli C
    Transl Res; 2016 May; 171():83-95.e1-2. PubMed ID: 26925708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
    Kwon M; MacLeod TJ; Zhang Y; Waisman DM
    Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.
    MacLeod TJ; Kwon M; Filipenko NR; Waisman DM
    J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Annexin A2/S100A10 Complex: The Mutualistic Symbiosis of Two Distinct Proteins.
    Bharadwaj A; Kempster E; Waisman DM
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annexin A2-S100A10 heterotetramer is upregulated by PML/RARĪ± fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.
    Huang D; Yang Y; Sun J; Dong X; Wang J; Liu H; Lu C; Chen X; Shao J; Yan J
    Front Med; 2017 Sep; 11(3):410-422. PubMed ID: 28687976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: an enduring ambiguity.
    Bydoun M; Waisman DM
    Future Oncol; 2014 Dec; 10(15):2469-79. PubMed ID: 25525855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple functions of S100A10, an important cancer promoter.
    Saiki Y; Horii A
    Pathol Int; 2019 Nov; 69(11):629-636. PubMed ID: 31612598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p11/S100A10 light chain of annexin A2 is dispensable for annexin A2 association to endosomes and functions in endosomal transport.
    Morel E; Gruenberg J
    PLoS One; 2007 Oct; 2(10):e1118. PubMed ID: 17971878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Ion Channels and Receptors by p11 (S100A10).
    Seo JS; Svenningsson P
    Trends Pharmacol Sci; 2020 Jul; 41(7):487-497. PubMed ID: 32418644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10.
    Madureira PA; Bharadwaj AG; Bydoun M; Garant K; O'Connell P; Lee P; Waisman DM
    Oncotarget; 2016 Jul; 7(30):47720-47737. PubMed ID: 27351226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of a C-terminal AHNAK peptide in a 1:2:2 complex with S100A10 and an acetylated N-terminal peptide of annexin A2.
    Ozorowski G; Milton S; Luecke H
    Acta Crystallogr D Biol Crystallogr; 2013 Jan; 69(Pt 1):92-104. PubMed ID: 23275167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer.
    Lokman NA; Ho R; Gunasegaran K; Bonner WM; Oehler MK; Ricciardelli C
    J Exp Clin Cancer Res; 2019 Jan; 38(1):10. PubMed ID: 30621740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin.
    Wang L; Yan W; Li X; Liu Z; Tian T; Chen T; Zou L; Cui Z
    J Ovarian Res; 2019 Nov; 12(1):113. PubMed ID: 31739800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A10/p11: family, friends and functions.
    Rescher U; Gerke V
    Pflugers Arch; 2008 Jan; 455(4):575-82. PubMed ID: 17638009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The S100A10-annexin A2 complex provides a novel asymmetric platform for membrane repair.
    Rezvanpour A; Santamaria-Kisiel L; Shaw GS
    J Biol Chem; 2011 Nov; 286(46):40174-83. PubMed ID: 21949189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.
    Bharadwaj AG; Kempster E; Waisman DM
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca
    Lindsay S; Bartolotti L; Li Y
    Proteins; 2023 Aug; 91(8):1042-1053. PubMed ID: 36965169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A10-mediated translocation of annexin-A2 to SNARE proteins in adrenergic chromaffin cells undergoing exocytosis.
    Umbrecht-Jenck E; Demais V; Calco V; Bailly Y; Bader MF; Chasserot-Golaz S
    Traffic; 2010 Jul; 11(7):958-71. PubMed ID: 20374557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes.
    Laumonnier Y; Syrovets T; Burysek L; Simmet T
    Blood; 2006 Apr; 107(8):3342-9. PubMed ID: 16373665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.